Login / Signup

Fluvoxamine used to treat COVID-19 resulting in theophylline toxicity from CYP 1A2 drug-drug interaction.

Jon B ColeRebecca B MeinersStacey A Bangh
Published in: Clinical toxicology (Philadelphia, Pa.) (2022)
Keyphrases
  • coronavirus disease
  • sars cov
  • oxidative stress
  • adverse drug
  • emergency department
  • respiratory syndrome coronavirus
  • electronic health record